RE:RE:Proxy Form - A Call to Action!1) I also want Majescor to succeed, but Michel already gets paid for sitting on the Board of Majescor (and he gets options too). Giving him options that derive their success from CARA will not incentivize him to do a better job selling CARDS. He did not contribute anything to CARA (he is a salesman, not a scientist).
2) CARDS was an expensive failure for Diagnos, and some of the blame belongs to Michel. The software cost millions of dollars to develop, but it never produced positive cash flows for the company, and it was sold for less than it cost to develop. In the article you posted, Michel says that Goldcorp is using Watson AI. Why aren't they using CARDS instead?
3) It's a lot of money that is being paid for failure. I can't understand why. Those options could easily be worth hundreds of thousands of dollars, but CARDS itself was sold for hundreds of thousands of dollars. My experience in life, is that the simplest explanation is usually correct: Andre is overpaying these Quebecois because he is friends with them. That is why shareholders must send him a message.
Vote Against the Appointment of Jean-Yves Therien to the Board.
Note: I would be happy to give those 1.1 million options to scientists that actually contributed to the development of CARA. We should reward success, not failure.